Shelley Force Aldred, Ph.D.

Co-Founder & CEO at Rondo Therapeutics

Speaker

Shelley Force Aldred is CEO and Co-founder of Rondo Therapeutics, an emerging biopharmaceutical company developing bispecific therapeutic antibodies that enable controlled activation of the immune system to fight cancer. Previously, Dr. Force Aldred was a member of TeneoBio’s founding team where she led preclinical development for the company’s CD3 T-cell engager platform which ultimately generated $1.5B in up-front payments through partnerships and an acquisition by Amgen. Early in her career, Dr. Force Aldred earned a Ph.D. in Genetics from Stanford and developed a passion for starting companies when she co-founded SwitchGear Genomics which later sold to Active Motif.